USA – FDA drafts guidance on classification category for biosimilar supplements

Fiche du document

Auteur
Date

12 mars 2024

Types de document
Périmètre
Identifiant
Source

ELSIBI

Organisation

OpenEdition

Licence

info:eu-repo/semantics/openAccess



Citer ce document

vroby, « USA – FDA drafts guidance on classification category for biosimilar supplements », ELSIBI, ID : 10.58079/w08c


Métriques


Partage / Export

Résumé 0

The US Food and Drug Administration (FDA) just published draft guidance to assist sponsors determine the appropriate supplement category for biosimilar applications and its goals for reviewing them. The guidance also describes the process for submitting supplements. The FDA Draft guidance can be found on its website. More information on RIS.World.

document thumbnail

Par les mêmes auteurs

Sur les mêmes sujets

Sur les mêmes disciplines

Exporter en